Sarantis Worldwide


Visit our group site

Sarantis Group| English

Or choose a location

INVESTOR'S PRESS

IR Releases

16 OCTOBER 2024

Purchase of own shares

SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on October 15th 2024 with the purchase of 6,669 own shares at the average price of 10.

15 OCTOBER 2024

Purchase of own shares

SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on October 14th 2024 with the purchase of 9,100 own shares at the average price of 10.

14 OCTOBER 2024

Sarantis Group: Pharmacy Company of the Year and Nine Awards for Lanes, Clinéa & PIC at the Best in Pharmacy Awards 2024

Sarantis Group has once again confirmed its strong presence in the pharmaceutical market by winning nine significant awards at the Best in Pharmacy Awards 2024. Organized for the 7th consecutive year in Greece by BOUSSIAS Events, these awards recognize outstanding performance in pharmacy products, creativity, and strategic marketing practices that promote these products in the market.

14 OCTOBER 2024

Purchase of own shares

SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on October 11th 2024 with the purchase of 4,934 own shares at the average price of 10.

11 OCTOBER 2024

Purchase of own shares

SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on October 10th 2024 with the purchase of 7,377 own shares at the average price of 10.

10 OCTOBER 2024

Purchase of own shares

SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on October 9th 2024 with the purchase of 2,329 own shares at the average price of 10.

9 OCTOBER 2024

Lanes Celebrates Double Recognition at the 2024 Supplement Awards

Lanes, the leading brand in the nutritional supplements sector of Sarantis Group, received two significant Awards at the Supplement Awards 2024, organized by BOUSSIAS events, once again confirming its leadership position in the market.

9 OCTOBER 2024

Purchase of own shares

SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on October 8th 2024 with the purchase of 9,520 own shares at the average price of 10.

Press Releases

Want to learn more about the Group?
Explore our latest news regarding our brands, our activities, our people and our sustainability actions!

More
Change cookies consent Revoke cookies consent